CAS: 16271-33-3; 2,4-Dichlorobenzenesulfonyl Chloride

该化合物是有机化合物,其特征是附在二氯苯环上的全氟辛烷磺酸功能组,该化合物一般看起来色色无色,为黄色固体,由于存在二氯苯基组,其反应性很强,特别是核糖分泌物,因此众所周知,该化合物在有机合成中通常用作试剂,特别是用于将全氟辛烷磺酸组引入各种子体;该化合物还用于制作磺酰胺和其他磺酰氟衍生物;该化合物的活性作用使得该物质在制药和农用化学物中的重要性;然而,由于该物质具有腐蚀性,而且可能对皮肤,眼睛和呼吸系统造成刺激,因此必须谨慎处理该物质;在与该化学品合作时,建议采取适当的安全防范措施,包括使用个人防护设备并在通风良好的地区工作.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号541-73-1 间二氯苯 | CAS号609-62-1 2, 4-二氯苯磺酸 | CAS号7790-94-5 氯磺酸 | CAS号67-66-3 氯仿 | CAS号7664-93-9 硫酸 | CAS号105456-57-3 4-[(2,4-Dichlor... | CAS号372-18-9 1,3-二氟苯 | CAS号20532-15-4 2,4-二氯苯磺酰胺 | CAS号15433-50-8 Disulfide,bis(2... | CAS号1122-41-4 2,4-二氯苯硫酚 | CAS号315224-26-1 2,4-二氯-N-[3,5-二... | CAS号98491-03-3 2,4-dichloro-N,... | CAS号61945-91-3 4-(benzenesulfo... | CAS号38064-02-7 (2,4-dichloroph...

合成工艺路线路线简述

  • 合成目标产物 2,4-Dichlorobenzenesulfonyl Chloride 主要起始原料 2,4-Dichloroaniline
  • (文献来源)合成步骤主要原料 2,4-Dichloroaniline
1,3-二氯苯置于磺酰氯,硫酸体系中,用 N,N-二甲基甲酰胺 用作溶剂,化学反应 2.5H,以62%的收率获得2,4-二氯苯磺酰氯
参考文献:Sulfonyl Chloride As A Disposable Electron Withdrawing Substituent In Halex Fluorinations
标题:Sulfonyl Chloride As A Disposable Electron Withdrawing Substituent In Halex Fluorinations
摘要:Syntheses Of 1,3-Difluorobenzene And 2,6-Difluorotoluene Are Described Via Chlorosulfonation,Catalytic Halex-Fluorination,And Desulfination Of 1,3-Dichlorobenzene And 2,6-Dichlorotoluene. (C) 2000 Elsevier Science S.A. All Rights Reserved.
Doi:10.1016/s0022-1139(99)00195-5

海关参考信息

专利信息


专利号:US-2012053350-A1
优先权日:2009-04-30
标题 :Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids
发明人:MANGION IAN; HUFFMAN MARK A; RUCK REBECCA T; LYNCH JOSEPH; CHUNG JOHN Y L; MARCUNE BENJAMIN
权利人:MANGION IAN; HUFFMAN MARK A; RUCK REBECCA T; LYNCH JOSEPH; CHUNG JOHN Y L; MARCUNE BENJAMIN
摘要:A process for the preparation of alkyl esters of N-protected oxo-azacycloalkylcarboxylic acids of Formula III: comprises contacting a ketosulfoxonium ylide of Formula II: with an iridium catalyst to obtain Compound III, wherein P G1 is an amine protective group; k is 0, 1, or 2; and R U , R 1 , R 2 , and R 3 are defined herein. An embodiment of the process further com rises contacting a compound of Formula I: with a sulfoxonium halide of formula (R U ) 3 S(O)Z, wherein Z is halide, in the presence of a strong base to obtain Compound II. Additional embodiments add a series of process steps leading to the synthesis of 7-oxo-1,6-diazabicyclo[3.2.1]octanes suitable for use as β-lactamase inhibitors.

专利号:US-9604985-B2
优先权日:2013-06-10
标 题 :Process for the preparation of chiral tert-butyl 4-((1R,2S,5R)-6(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)piperidine-1-carb derivatives and (2S,5R)-7-oxo-N-piperidin-4-yl-6-(sulfoxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide
发明人:MILLER STEVEN P; LIMANTO JOHN; ZHONG YONG-LI; YASUDA NOBUYOSHI; LIU ZHIJIAN
权利人:MERCK SHARP & DOHME
摘要:A process for the preparation of N-protected 6-(piperidin-4-ylcarbamoyl)piperidin-3-yl sulfonates of Formula (III): which comprises contacting a lactone of Formula (II): with an azacycloalkylamine of formula (II-Am): followed by contact with a sulfonyl halide of formula (II-Su): R 4 —SO 2 W (II-Su) in the presence of tertiary amine base, wherein P G1 and P G2 are amine protective groups; k, p and q are 0, 1, or 2, and W, R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 are defined herein. Additional embodiments add a series of process steps leading to the synthesis of 7-oxo-1,6-diazabicyclo[3.2.1]octanes suitable for use as β-lactamase inhibitors.

专利号:US-2022363662-A1
优先权日:2021-04-20
标题 :Compounds as lxr agonists
发明人:PUJALA BRAHMAM; SATHE BALAJI DASHRATH; DANODIA ABHINANDAN; GUPTA ASHU; SONI SANJEEV; KUMAR VIVEK; ANSARI AMANTULLAH; KHAN FARHA; SARKAR ARINDAM; PAYGHAN PAVAN V
权利人:INTEGRAL BIOSCIENCES PRIVATED LTD
摘要:The present invention generally discloses compounds having LXR (the liver X receptor) agonistic activity, to the use of such compounds in the treatment of various disorders such as proliferative disorders, Alzheimer's disease, inflammatory diseases, and diseases characterized by defects in cholesterol and lipid metabolism. Specifically, the present invention discloses compound of formula (IA) which exhibit LXR agonist activity, specifically to LXRβ. The invention also discloses method of synthesis of said compounds, method of using said compounds, pharmaceutical compositions comprising said compounds and method of using thereof.

专利号:US-6531470-B1
优先权日:1998-01-23
标题:Oxazolidinone combinatorial libraries, compositions and methods of preparation
发明人:GORDEEV MIKHAIL F; LUEHR GARY W; PATEL DINESH V; NI ZHI-JIE; GORDON ERIC
权利人:UPJOHN CO
摘要:Oxazolidinones and methods for their synthesis are provided. Also provided are combinatorial libraries comprising oxazolidinones, and methods to prepare the libraries. Further provided are methods of making biologically active oxazolidinones as well as pharmaceutically acceptable compositions comprising the oxazolidinones. The methods of library preparation include the attachment of oxazolidinones to a solid support. The methods of compound preparation in one embodiment involve the reaction of an iminophosphorane with a carbonyl containing polymeric support.

专利号:EP-3515880-B1
优先权日:2017-03-17
标题:Methods and compositions for synthesis of encoded libraries
发明人:LI JIN; MORGAN BARRY A; Wan jinqiao; DOU DENGFENG; LIU GUANSAI; CHANG YONG; CHEN QIUXIA; WANG XING; XU YANSHAN; HU DONGYAN; LIU JIAN; CHENG XUEMIN
权利人:HITGEN INC

专利号:US-2020149034-A1
优先权日:2017-03-17
标题:Methods and Compositions for Synthesis of Encoded Libraries
科邦特化工(杭州)有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.capot.cn
企业联系电话:0571-85586718👤
📞科邦特化工(杭州)有限公司 ⚠️参考联系方式
联系人:景先生
电话:0571-85586718
手机:13336094967(外贸专线);13336195806(内需专线)
传真:0571-85864795
邮箱:sales@capot.com
通信地址: 浙江省杭州市滨江区江陵路88号万轮科技园
邮编: 310051
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:浙江省杭州市滨江区江陵路88号万轮科技园
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
常州市宣明医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://xuanmingchem.com
企业联系电话:0519-85525329👤
📞常州市宣明医药科技有限公司 ⚠️参考联系方式
联系人:刘明;许雯
电话:0519-85525329
手机:15951231113;13646117943
传真:0519-85190960
邮箱:sales@xuanmingchem.com
通信地址: 江苏省常州市新北区汉江路120号
邮编: 213000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:江苏省常州市新北区汉江路120号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
天津市嘉涵化工科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jiahanchem.com
电话: 18920613223 86-22-58055669👤
📞天津市嘉涵化工科技有限公司 ⚠️参考联系方式

销售电话:18920613223 86-22-58055669
邮箱:sales@jiahanchem.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals., NX#05079
参考文献:10.1107/s1600536810035166
摘要:Gowda BT, Foro S, Nirmala PG, Fuess H. 2,4-Dichloro-N-(2-methyl-phen-yl)benzene-sulfonamide. Acta Crystallogr Sect E Struct Rep Online. 2010 Sep 11;66(Pt 10):o2542.
参考文献:10.1107/s1600536810020106
摘要:Gowda BT, Foro S, Nirmala PG, Fuess H. 2,4-Dichloro-N-(3-methyl-phen-yl)benzene-sulfonamide. Acta Crystallogr Sect E Struct Rep Online. 2010 Jun 05;66(Pt 7):o1520.
参考文献:10.1107/s1600536810020349
摘要:Gowda BT, Foro S, Nirmala PG, Fuess H. 2,4-Dichloro-N-(3-chloro-phen-yl)benzene-sulfonamide. Acta Crystallogr Sect E Struct Rep Online. 2010 Jun 05;66(Pt 7):o1552.
参考文献:10.1107/s1600536810021306
摘要:Gowda BT, Foro S, Nirmala PG, Fuess H. 2,4-Dichloro-N-(2-chloro-phen-yl)benzene-sulfonamide. Acta Crystallogr Sect E Struct Rep Online. 2010 Jun 16;66(Pt 7):o1641.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知